EP Patent

EP3545950A1 — Pharmaceutical composition comprising brexpiprazole

Assigned to Adamed Sp zoo · Expires 2019-10-02 · 7y expired

What this patent protects

The present invention relates to a pharmaceutical composition comprising a granulate comprising brexpiprazole, wherein the granulate is obtained by wet-granulation of a carrier using a granulation liquid that is a solution of brexpiprazole in a solvent system. The present inventi…

USPTO Abstract

The present invention relates to a pharmaceutical composition comprising a granulate comprising brexpiprazole, wherein the granulate is obtained by wet-granulation of a carrier using a granulation liquid that is a solution of brexpiprazole in a solvent system. The present invention relates also to a granulate used in the pharmaceutical composition, and a unit dosage form comprising the pharmaceutical composition, and the method for manufacturing a pharmaceutical composition comprising brexpiprazole.

Drugs covered by this patent

Patent Metadata

Patent number
EP3545950A1
Jurisdiction
EP
Classification
—
Expires
2019-10-02
Drug substance claim
No
Drug product claim
No
Assignee
Adamed Sp zoo
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.